DelveInsight’s “Substance Use Disorder Market Insights, Epidemiology, and Market Forecast 2034” report delivers an in-depth understanding of Substance Use Disorder, historical and forecasted epidemiology as well as the Substance Use Disorder market trends in the United States, EU4 (Germany, Spain, Italy, France) and the United Kingdom, and Japan.
Discover which therapies are expected to grab the Substance Use Disorder Market Share @ Substance Use Disorder Market Outlook
Key Takeaways from the Substance Use Disorder Market Report
- The increase in Substance Use Disorder Market Size is a direct consequence of the increasing patient population and anticipated launch of emerging therapies in the 7MM.
- The United States generated revenue of approximately USD 3000 million in 2023.
- The leading Substance Use Disorder Companies such as BioXcel Therapeutics, NFL Biosciences, STALICLA, Embera NeuroTherapeutics, PleoPharma, Kinnov Therapeutics, Imbrium Therapeutics, Atai Life Sciences, Beckley Psytech, and others.
- Promising Substance Use Disorder Pipeline Therapies such as Mavoglurant (STP7/AFQ056), BPL-003 (Mebufotenin), INDV-2000, EMB-001, NFL-101, TMP-301, and others.
Stay ahead in the Substance Use Disorder Therapeutics Market with DelveInsight’s Strategic Report @ Substance Use Disorder Market Outlook
Substance Use Disorder Epidemiology Segmentation in the 7MM
The epidemiology section of Substance Use Disorder offers insights into both historical and current patient populations, as well as forecasted trends across seven major countries. This section aids in understanding the factors behind present and projected trends through analysis of various studies and input from key opinion leaders. Additionally, this portion of the market report provides information on the diagnosed patient pool, trends, and underlying assumptions.
Download the report to understand which factors are driving Substance Use Disorder Epidemiology trends @ Substance Use Disorder Prevalence
Substance Use Disorder Drugs Market
The Substance Use Disorder Drugs Market is expected to witness substantial growth in the coming years as more targeted therapies receive regulatory approval and enter clinical practice. Additionally, ongoing research efforts aimed at better understanding the molecular mechanisms underlying Substance Use Disorder are likely to uncover new therapeutic targets and further expand treatment options for patients.
Substance Use Disorder Treatment Market Landscape
The Substance Use Disorder treatment market landscape has witnessed significant advancements over the past years, with targeted therapies playing a crucial role in improving outcomes for patients. Among these targeted therapies, the emergence of long-acting formulations, abuse-deterrent medications, and novel neurobiological targets has garnered attention in the medical community, presenting both challenges and opportunities in treatment strategies.
To learn more about Substance Use Disorder treatment guidelines, visit @ Substance Use Disorder Treatment Market Landscape
Substance Use Disorder Market Outlook
The report’s outlook on the Substance Use Disorder market aids in developing a comprehensive understanding of historical, current, and projected trends. This is achieved by examining the influence of existing Substance Use Disorder therapies, unmet needs, as well as drivers, barriers, and the demand for advanced technology. This section provides detailed insights into the trends of each marketed Substance Use Disorder drug and late-stage pipeline therapy.
Substance Use Disorder Drugs Uptake
The drug chapter of the Substance Use Disorder report provides a comprehensive analysis of both marketed drugs and late-stage pipeline drugs for this condition. It delves into the details of clinical trials, pharmacological actions, agreements, collaborations, approvals, patents, and advantages, and disadvantages of each drug, as well as the latest news and press releases related to Substance Use Disorder.
Major Substance Use Disorder Companies
BioXcel Therapeutics, NFL Biosciences, STALICLA, Embera NeuroTherapeutics, PleoPharma, Kinnov Therapeutics, Imbrium Therapeutics, Atai Life Sciences, Beckley Psytech, and others.
Learn more about the FDA-approved drugs for Substance Use Disorder @ Drugs for Substance Use Disorder Treatment
Scope of the Substance Use Disorder Market Report
- Coverage- 7MM
- Study Period- 2020-2034
- Substance Use Disorder Companies- BioXcel Therapeutics, NFL Biosciences, STALICLA, Embera NeuroTherapeutics, PleoPharma, Kinnov Therapeutics, Imbrium Therapeutics, Atai Life Sciences, Beckley Psytech, and others.
- Substance Use Disorder Pipeline Therapies- Mavoglurant (STP7/AFQ056), BPL-003 (Mebufotenin), INDV-2000, EMB-001, NFL-101, TMP-301, and others.
- Substance Use Disorder Market Dynamics: Substance Use Disorder Market Drivers and Barriers
- Substance Use Disorder Market Access and Reimbursement, Unmet Needs and Future Perspectives
Discover more about Substance Use Disorder Drugs in development @ Substance Use Disorder Clinical Trials Assessment
Table of Content
1. Key Insights
2. Report Introduction
3. Substance Use Disorder Market Overview at a Glance
4. Methodology
5. Executive Summary
6. Key Events
7. Disease Background and Overview
8. Treatment and Management of Substance Use Disorder
9. Substance Use Disorder Epidemiology and Patient Population
10. Substance Use Disorder Patient Journey
11. Substance Use Disorder Marketed Therapies
12. Emerging Substance Use Disorder Therapies
13. Substance Use Disorder (SUD): 7 Major Market Analysis
14. KOL Views
15. SWOT Analysis
16. Substance Use Disorder Unmet Needs
17. Market Access and Reimbursement
18. Appendix
19. DelveInsight Capabilities
20. Disclaimer
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Contact Information
Kanishk
